Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma exchange with albumin replacement in adrenomyeloneuropathy
2019-004733-17Phase 2Completed
- Sponsor
- Aurora Pujol Onofre
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human) in adrenomyeloneuropathy (AMN), sponsored by Aurora Pujol Onofre. Primary endpoint: Change in plasma VLCFA levels. Started Dec 2019; status: completed.
02
Drugs
albumin (human)
03
Conditions
adrenomyeloneuropathy (AMN)
Beyond the preview
Go deeper on 2019-004733-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004733-17.